Genomic Classifier Performance in Intermediate-Risk Prostate Cancer: Results From NRG Oncology/RTOG 0126 Randomized Phase 3 Trial
Daniel E. Spratt, Vinnie Y.T. Liu, Jeff M. Michalski, Elai Davicioni, Alejandro Berlín, Jeffry Simko, Jason A. Efstathiou, Phuoc T. Tran, Howard M. Sandler, William A. Hall, Darby J.S. Thompson, Matthew Parliament, Ian S. Dayes, Rohann Correa, John M. Robertson, Elizabeth Gore, Desiree E. Doncals, Éric Vigneault, Luís Souhami, Theodore Karrison, Felix Y. Feng
Topics & Concepts
MedicineProstate cancerInternal medicineOncologyHazard ratioClinical endpointRandomized controlled trialHormonal therapyCancerProstateConfidence intervalProstate Cancer Diagnosis and TreatmentProstate Cancer Treatment and ResearchBreast Cancer Treatment Studies